138 related articles for article (PubMed ID: 18166847)
1. Thymic carcinoid responds to neoadjuvant therapy with sunitinib and octreotide: a case report.
Dham A; Truskinovsky AM; Dudek AZ
J Thorac Oncol; 2008 Jan; 3(1):94-7. PubMed ID: 18166847
[TBL] [Abstract][Full Text] [Related]
2. Metastatic thymic carcinoid responds to chemoradiation and octreotide: A case report.
Mei Z; Wang H; Ren S; Wei J; Gu Y
Medicine (Baltimore); 2018 Nov; 97(47):e13286. PubMed ID: 30461637
[TBL] [Abstract][Full Text] [Related]
3. [Two cases of thymic carcinoid treated with octreotide long-acting repeatable].
Okabe N; Inoue T; Watanabe Y; Muto S; Hasegawa T; Ohsugi J; Higuchi M; Shio Y; Suzuki H
Gan To Kagaku Ryoho; 2014 Jul; 41(7):879-83. PubMed ID: 25131876
[TBL] [Abstract][Full Text] [Related]
4. Thymic neuroendocrine tumour (carcinoid): clinicopathological features of four patients with different presentation.
Dutta R; Kumar A; Julka PK; Mathur SR; Kaushal S; Kumar R; Jindal T; Suri V
Interact Cardiovasc Thorac Surg; 2010 Dec; 11(6):732-6. PubMed ID: 20851876
[TBL] [Abstract][Full Text] [Related]
5. Everolimus in combination with octreotide LAR in thymic atypical carcinoid.
Sakane T; Nakano T; Hagui E; Haneda H; Okuda K
Thorac Cancer; 2023 May; 14(15):1404-1407. PubMed ID: 37037489
[TBL] [Abstract][Full Text] [Related]
6. Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
Schirosi L; Nannini N; Nicoli D; Cavazza A; Valli R; Buti S; Garagnani L; Sartori G; Calabrese F; Marchetti A; Buttitta F; Felicioni L; Migaldi M; Rea F; Di Chiara F; Mengoli MC; Rossi G
Ann Oncol; 2012 Sep; 23(9):2409-2414. PubMed ID: 22357254
[TBL] [Abstract][Full Text] [Related]
7. [Bronchopulmonary carcinoid tumours].
Rena O; Filosso PL; Ruffini E; Oliaro A
Minerva Chir; 2002 Aug; 57(4):403-23. PubMed ID: 12145571
[TBL] [Abstract][Full Text] [Related]
8. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids.
Jianu CS; Fossmark R; Syversen U; Hauso Ø; Fykse V; Waldum HL
Scand J Gastroenterol; 2011 Apr; 46(4):456-63. PubMed ID: 21133821
[TBL] [Abstract][Full Text] [Related]
9. Atypical presentation of an atypical carcinoid.
Van Brandt V; Heyman S; Van Marck E; Hendriks J; Van Schil P
Ann Thorac Surg; 2009 Dec; 88(6):2004-6. PubMed ID: 19932277
[TBL] [Abstract][Full Text] [Related]
10. [Gammagraphy of somatostatin receptors in an ACTH secreting thymic carcinoid].
Banzo J; Razola P; Prats E; Freile E; Benito JL; García López F; García Tirado J; Abós MD
Rev Esp Med Nucl; 1999; 18(2):99-103. PubMed ID: 10352322
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of long-acting octreotide in the treatment of thymic tumors: results of a pilot trial.
Longo F; De Filippis L; Zivi A; Vitolo D; Del Signore E; Gori B; Diso D; Anile M; Venuta F; De Giacomo T; Coloni CF
Am J Clin Oncol; 2012 Apr; 35(2):105-9. PubMed ID: 21325939
[TBL] [Abstract][Full Text] [Related]
12. [A case of rectal carcinoid with multiple liver, lymph nodes and bone metastases that responded to an octreotide therapy].
Yamashita K; Takase S; Nakamura T; Matsuda Y; Imanishi T; Sumi Y; Suzuki S; Kamigaki T; Ku Y; Kuroda D
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2349-51. PubMed ID: 21224569
[TBL] [Abstract][Full Text] [Related]
13. Carcinoid of the pancreas.
Migliori M; Tomassetti P; Lalli S; Casadei R; Santini D; Corinaldesi R; Gullo L
Pancreatology; 2002; 2(2):163-6. PubMed ID: 12123097
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of octreotide in the regression of a metastatic carcinoid tumour despite negative imaging with In-111-pentetreotide (Octreoscan).
Hillman N; Herranz L; Alvarez C; Martínez Olmos MA; Márco A; Gómez-Pan A
Exp Clin Endocrinol Diabetes; 1998; 106(3):226-30. PubMed ID: 9710364
[TBL] [Abstract][Full Text] [Related]
15. [Carcinoid tumor of the thymus].
Nagai K; Gi H; Kiguchi T; Takizawa N; Taguchi M; Kato H; Ebihara Y
Kyobu Geka; 1993 Jul; 46(7):590-4. PubMed ID: 8336436
[TBL] [Abstract][Full Text] [Related]
16. [Metastasized carcinoid tumor treated with interferon and octreotide].
Szilvás A; Székely G; Szilvási I; Jakab F
Orv Hetil; 1998 Oct; 139(41):2455-8. PubMed ID: 9805460
[TBL] [Abstract][Full Text] [Related]
17. Carcinoid tumors of the lung and multimodal therapy.
Divisi D; Crisci R
Thorac Cardiovasc Surg; 2005 Jun; 53(3):168-72. PubMed ID: 15926097
[TBL] [Abstract][Full Text] [Related]
18. [Thymic carcinoid: CT and MR findings].
Ferrozzi F; Ganzetti A; Mugnoli E; Campodonico F; Campani R
Radiol Med; 1997 Dec; 94(6):652-6. PubMed ID: 9524605
[TBL] [Abstract][Full Text] [Related]
19. Thymic neuroendocrine carcinoma (carcinoid): what if octreotide scanning is negative?
Whitaker D
J Thorac Cardiovasc Surg; 2004 Nov; 128(5):801; author reply 801. PubMed ID: 15514629
[No Abstract] [Full Text] [Related]
20. In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
Lastoria S; Vergara E; Palmieri G; Acampa W; Varrella P; Caracò C; Bianco RA; Muto P; Salvatore M
J Nucl Med; 1998 Apr; 39(4):634-9. PubMed ID: 9544670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
